Home

Pfizer, Inc. - Financial Overview

Ticker - PFE

Close PriceMarket CapP/E RatioForward P/E RatioImplied Growth*Implied Forward Growth*P/B Ratio
$22.14$125.57B15.77.68.9%1.5%1.4

Revenue and Net Income Chart EPS Chart
  Date Revenue Net Income EPS Revenue Change Net Income Change EPS Change
0 2020-12-31 $41.7B $9.2B $1.73 N/A N/A N/A
1 2021-12-31 $81.3B $22.0B $3.92 95.2% 140.0% 126.6%
2 2022-12-31 $100.3B $31.4B $5.59 23.4% 42.7% 42.6%
3 2023-12-31 $58.5B $2.1B $0.38 -41.7% -93.2% -93.2%
4 2024-12-31 $63.6B $8.0B $0.38 8.8% 279.0% 0.0%
5 TTM 2024-12-31 $63.6B $8.0B $1.41 -0.0% 0.0% 271.1%
6 Average 17.1% 73.7% 69.4%




PFE - Forecast Data



PFE - Y/Y % Change

  Metric Value
0 Total Assets $213,396M
1 Cash $1,043M
2 Total Liabilities $124,899M
3 Total Debt $63,649M
4 Total Equity $88,203M
5 Debt to Equity Ratio 0.72
PFE Balance Sheet Chart



PFE - Valuation Chart


Valuation Chart

Share Price Treasury Yield Estimates Fair Value (P/E) Fair Value (P/S) Current P/S Current P/E
$22.14 4.3% Nicks Growth: 2%
Nick's Expected Margin: 10%
FINVIZ Growth: -1%
Nicks: 8
Finviz: 6
Nick's: 0.794 2.0 15.7
Basis Year Nicks Valuation Nicks vs Share Price Finviz Valuation Finviz vs Share Price
$1.41 EPS TTM $11.20 -49.4% $7.83 -64.6%
$2.98 EPS 2025 $23.66 6.9% $16.55 -25.2%
$3.00 EPS 2026 $23.82 7.6% $16.66 -24.8%